January 20, 2025) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce an expansion of the Copper Mountain Project Area, from approximately ...
When players exit the cramped visiting locker room inside Kansas City's Arrowhead Stadium, make their way down a narrow hallway and prepare to enter the field to face the Chiefs, they are greeted ...
December 23, 2024--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company’s ...
Arrowhead also filed recently a request for regulatory clearance to initiate a clinical trial for its second obesity candidate, ARO-ALK7. Both ARO-INHBE and ARO-ALK7 are designed to intervene in a ...